These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 30049226)
1. Cost-effectiveness analysis of iStent trabecular micro-bypass stent for patients with open-angle glaucoma in Colombia. Ordóñez JE; Ordóñez A; Osorio UM Curr Med Res Opin; 2019 Feb; 35(2):329-340. PubMed ID: 30049226 [TBL] [Abstract][Full Text] [Related]
2. Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma. Berdahl JP; Khatana AK; Katz LJ; Herndon L; Layton AJ; Yu TM; Bauer MJ; Cantor LB J Med Econ; 2017 Jul; 20(7):760-766. PubMed ID: 28471282 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada. Patel V; Ahmed I; Podbielski D; Falvey H; Murray J; Goeree R J Med Econ; 2019 Apr; 22(4):390-401. PubMed ID: 30663456 [TBL] [Abstract][Full Text] [Related]
4. A European perspective on costs and cost effectiveness of ophthalmic combinations in the treatment of open-angle glaucoma. Hommer A; Thygesen J; Ferreras A; Wickstrom J; Friis MM; Buchholz P; Walt JG Eur J Ophthalmol; 2008; 18(5):778-86. PubMed ID: 18850558 [TBL] [Abstract][Full Text] [Related]
5. Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America. Susanna R; Sheu WP; Clin Ther; 2004 May; 26(5):755-68. PubMed ID: 15220019 [TBL] [Abstract][Full Text] [Related]
6. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Orzalesi N; Rossetti L; Bottoli A; Fumagalli E; Fogagnolo P Arch Ophthalmol; 2003 Apr; 121(4):453-7. PubMed ID: 12695241 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension. Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402 [TBL] [Abstract][Full Text] [Related]
8. Implantation of two second-generation trabecular micro-bypass stents and topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 18-month follow-up. Berdahl J; Voskanyan L; Myers JS; Hornbeak DM; Giamporcaro JE; Katz LJ; Samuelson TW Clin Exp Ophthalmol; 2017 Nov; 45(8):797-802. PubMed ID: 28384377 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials. Fechtner RD; Airaksinen PJ; Getson AJ; Lines CR; Adamsons IA; Acta Ophthalmol Scand; 2004 Feb; 82(1):42-8. PubMed ID: 14982045 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece. Petounis A; Mylopoulos N; Kandarakis A; Andreanos D; Dimitrakoulias N J Glaucoma; 2001 Aug; 10(4):316-24. PubMed ID: 11558817 [TBL] [Abstract][Full Text] [Related]
11. Ocular Antihypertensive Medication Use After iStent Implantation Concurrent With Cataract Surgery vs Cataract Surgery Alone in a Large US Health Care Claims Database. Wang SY; Singh K; Stein JD; Chang RT JAMA Ophthalmol; 2019 Jan; 137(1):21-27. PubMed ID: 30267072 [TBL] [Abstract][Full Text] [Related]
12. Trabecular micro-bypass stent implantation during small-incision cataract surgery for open-angle glaucoma or ocular hypertension: Long-term results. Neuhann TH J Cataract Refract Surg; 2015 Dec; 41(12):2664-71. PubMed ID: 26796447 [TBL] [Abstract][Full Text] [Related]
13. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy. Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406 [TBL] [Abstract][Full Text] [Related]
14. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability. Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832 [TBL] [Abstract][Full Text] [Related]
15. A Canadian Cost-Utility Analysis of 2 Trabecular Microbypass Stents at Time of Cataract Surgery in Patients with Mild to Moderate Open-Angle Glaucoma. Ahmed IIK; Podbielski DW; Patel V; Falvey H; Murray J; Botteman M; Goeree R Ophthalmol Glaucoma; 2020; 3(2):103-113. PubMed ID: 32672593 [TBL] [Abstract][Full Text] [Related]
16. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma. Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034 [TBL] [Abstract][Full Text] [Related]
17. Latanoprost versus timolol as first choice therapy in patients with ocular hypertension. A cost-effectiveness analysis. Peeters A; Schouten JS; Severens JL; Hendrikse F; Prins MH; Webers CA Acta Ophthalmol; 2012 Mar; 90(2):146-54. PubMed ID: 20731623 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines. Stewart WC; Konstas AG; Nelson LA; Kruft B Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886 [TBL] [Abstract][Full Text] [Related]
20. Latanoprost : an update of its use in glaucoma and ocular hypertension. Perry CM; McGavin JK; Culy CR; Ibbotson T Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]